Search by Drug Name or NDC
NDC 00409-1105-02 Atracurium Besylate 10 mg/mL Details
Atracurium Besylate 10 mg/mL
Atracurium Besylate is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hospira, Inc.. The primary component is ATRACURIUM BESYLATE.
Product Information
| NDC | 00409-1105 |
|---|---|
| Product ID | 0409-1105_926d60c7-8585-42f2-a9fc-02fcb51dc2ae |
| Associated GPIs | 74200010102020 |
| GCN Sequence Number | 008400 |
| GCN Sequence Number Description | atracurium besylate VIAL 10 MG/ML INTRAVEN |
| HIC3 | S7A |
| HIC3 Description | NEUROMUSCULAR BLOCKING AGENTS |
| GCN | 23390 |
| HICL Sequence Number | 003745 |
| HICL Sequence Number Description | ATRACURIUM BESYLATE |
| Brand/Generic | Generic |
| Proprietary Name | Atracurium Besylate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | ATRACURIUM BESYLATE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 10 |
| Active Ingredient Units | mg/mL |
| Substance Name | ATRACURIUM BESYLATE |
| Labeler Name | Hospira, Inc. |
| Pharmaceutical Class | Neuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA090761 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00409-1105-02 (00409110502)
| NDC Package Code | 0409-1105-02 |
|---|---|
| Billing NDC | 00409110502 |
| Package | 10 VIAL, MULTI-DOSE in 1 CARTON (0409-1105-02) / 10 mL in 1 VIAL, MULTI-DOSE (0409-1105-22) |
| Marketing Start Date | 2013-05-29 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |